GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) » Definitions » Other Stockholders Equity

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents (CAI:RMDA) Other Stockholders Equity : E£506 Mil (As of Mar. 2025)


View and export this data going back to 2019. Start your Free Trial

What is Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Stockholders Equity?

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Other Stockholders Equity for the quarter that ended in Mar. 2025 was E£506 Mil.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's quarterly Other Stockholders Equity increased from Sep. 2024 (E£525 Mil) to Dec. 2024 (E£530 Mil) but then declined from Dec. 2024 (E£530 Mil) to Mar. 2025 (E£506 Mil).

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's annual Other Stockholders Equity declined from Dec. 2022 (E£538 Mil) to Dec. 2023 (E£517 Mil) but then increased from Dec. 2023 (E£517 Mil) to Dec. 2024 (E£530 Mil).


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Stockholders Equity Historical Data

The historical data trend for Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Stockholders Equity Chart

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Stockholders Equity
Get a 7-Day Free Trial 508.04 513.69 537.67 516.91 529.94

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 516.91 516.91 525.28 529.94 506.07

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Business Description

Traded in Other Exchanges
N/A
Address
No. 5 Second Industrial Zone, Sixth of October City, Giza, EGY
Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents is a pharmaceutical company. The company is engaged in the manufacturing, marketing, selling, and storage of pharmaceutical reagents for both human and veterinary use. It is also involved in manufacturing, marketing, selling and storing diagnostic and pharmaceutical reagents for human, veterinary, and diagnostic use.

Tenth Of Ramadan For Pharmaceutical Industries And Diagnostic Reagents Headlines

No Headlines